Riskpilot← Back to searchSign inGet full accessROTNESLEGENE AS
ASActiveOrg 985541523Stasjonsveien 45, 1482 NittedalGeneral medical practice activities · NACE 8621Est. 20037 employees
Revenue 2025
NOK 6,3M
+6% vs 2024
EBITDA margin
0.8%
+61% vs 2024
Equity ratio
36.8%
Financial strength
Net profit 2025
NOK 20K
+152% vs 2024
| Revenue | NOK 6,3M | +6% |
| EBITDA | NOK 53K | +61% |
| Net profit | NOK 20K | +152% |
| Total assets | NOK 2,8M | +8% |
| Equity | NOK 1M | +2% |
| Employees | 7 | — |
Legal name
ROTNESLEGENE AS
Org number
985541523
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
7. april 2003
Share capital
NOK 120 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Helse og legetjenester og alt hva som står i forbindelse med dette.
Address
Stasjonsveien 45, 1482 Nittedal
Phone
+4767073650
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 967 | 5 614 | 5 517 | 5 997 | 6 336 |
| Staff expenses | −2 296 | −2 632 | −2 798 | −2 974 | −3 199 |
| EBITDA | 363 | 367 | 41 | 33 | 53 |
| Depreciation & amort. | −76 | −58 | −99 | −80 | −35 |
| EBIT | 288 | 309 | −58 | −47 | 18 |
| Net financials | −1 | 3 | 6 | 10 | 2 |
| Profit before tax | 286 | 312 | −52 | −38 | 20 |
| Tax | 67 | 65 | −0 | −0 | −0 |
| Net profit | 220 | 247 | −52 | −38 | 20 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 029 | 2 325 | 3 212 | 2 635 | 2 845 |
| Equity | 1 469 | 1 716 | 1 664 | 1 027 | 1 046 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 560 | 609 | 1 547 | 1 608 | 1 799 |
| Total debt | 560 | 609 | 1 547 | 1 608 | 1 799 |
EBITDA margin
0.8%
This company
15.8%
Market median
-95% vs market
20212025
Equity ratio
36.8%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
1.9%
This company
18.4%
Market median
-90% vs market
20212025
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20212025
Asset turnover
2.23×
This company
1.12×
Market median
+99% vs market
20212025
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MC Deputy Member | Deputy Member | 2015 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ROTNESLEGENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica Cyren Borg | Deputy Member | 0 companies |